Patent Assignment
Reel/Frame 074681/0643
Merger and Change of Name
Recorded: 2026-05-18
Pages: 3
Assignors
FRED HUTCHINSON CANCER RESEARCH CENTER
Executed: 2022-04-01
SEATTLE CANCER CARE ALLIANCE
Executed: 2022-04-01
Assignee
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Cancer Combination Therapies Utilizing a Nicotinamide Phosphoribosyltransferase Inhibitor in Combination with a Nicotinamide Adenine Dinucleotide Salvage Pathway Precursor
Application:
17/441,599 →
Publication:
US 2022/0125814
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 22, 2021
From: HOCKENBERY, DAVID M.; PADDISON, PATRICK
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 057566/0672 →
Merger and Change of Name
Jun 23, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060439/0279 →
Corrective Assignment to Correct the Patent Application Number 63/242,906 Previously Recorded on Reel 060439 Frame 0279. Assignor(S) Hereby Confirms the Merger and Change of Name.
Nov 4, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061847/0594 →
Confirmatory License
Dec 13, 2023
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065968/0293 →